dPCR, qPCR and RT-qPCR: Advantages and Challenges in Pre-clinical and Clinical Development
Check out our informative webinar titled "dPCR, qPCR, and RT-qPCR: Advantages and Challenges in Pre-clinical and Clinical Development," to gain insights into the best use of PCR methods in the pre-clinical and clinical development of vaccines and other biotherapeutics.
This webinar provides insight into regulated digital polymerase chain reaction (dPCR), quantitative polymerase chain reaction (qPCR), and reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) due to their extensive use in support of biodistribution, vector shedding, gene expression, chimeric antigen receptor (CAR) T cell therapy and oncolytic viral bioanalytical studies.
In this presentation, Manisha R. Diaz, Ph.D., Associate Director of Research & Development, Eurofins Viracor Biopharma, and Deepak Tomar, Ph.D., Senior Scientific Lab Lead, Eurofins Bioanalytical Services, review the advantages and disadvantages of dPCR, qPCR, and RT-qPCR as it relates to vaccine and biotherapeutic research. The featured speakers will also discuss the current method development and method validation best practices, context of use, and level of regulatory compliance required to support bioanalysis in the pre-clinical and clinical settings.